Ligand Pharmaceuticals Incorporated (LGND)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 72.52 |
| Open | 71.93 |
| Bid | 72.43 x 100 |
| Ask | 72.74 x 200 |
| Day's range | 71.16 - 72.95 |
| 52-week range | 49.24 - 94.57 |
| Volume | |
| Avg. volume | 169,445 |
| Market cap | 1.283B |
| Beta (5Y monthly) | 0.92 |
| PE ratio (TTM) | 23.92 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 02 Jul 2010 |
| 1y target est | N/A |
- Zacks
Wall Street Analysts Predict a 45.56% Upside in Ligand (LGND): Here's What You Should Know
The average of price targets set by Wall Street analysts indicates a potential upside of 45.6% in Ligand (LGND). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
- Zacks
Aptevo (APVO) Stock Plummets 79% in a Week: Here's Why
Aptevo (APVO) plunges after it issues secondary shares, which are not only issued at a significant discount but also substantially dilute the existing shareholder base.
- Zacks
Marinus (MRNS) Down 83% on Lead Drug Falling Short in Seizure Study
Interim results from a late-stage study show that Marinus' (MRNS) ganaxolone failed to meet the pre-specified stopping criteria in patients with refractory status epilepticus.
© 2024 Yahoo. All rights reserved.